• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Systemic dasatinib fails to prevent development of central nervous system progression in a patient with BCR-ABL unmutated Philadelphia chromosome-positive leukemia.

作者信息

Frigeri Ferdinando, Arcamone Manuela, Luciano Luigia, Di Francia Raffaele, Pane Fabrizio, Pinto Antonio

出版信息

Blood. 2009 May 14;113(20):5028-9. doi: 10.1182/blood-2008-11-191080.

DOI:10.1182/blood-2008-11-191080
PMID:19443672
Abstract
摘要

相似文献

1
Systemic dasatinib fails to prevent development of central nervous system progression in a patient with BCR-ABL unmutated Philadelphia chromosome-positive leukemia.在一名BCR-ABL未突变的费城染色体阳性白血病患者中，系统性使用达沙替尼未能预防中枢神经系统进展的发生。
Blood. 2009 May 14;113(20):5028-9. doi: 10.1182/blood-2008-11-191080.
2
Remission of Philadelphia chromosome-positive central nervous system leukemia after dasatinib therapy.达沙替尼治疗后费城染色体阳性中枢神经系统白血病的缓解
Leuk Lymphoma. 2007 May;48(5):1053-6. doi: 10.1080/10428190701258370.
3
Presence or the emergence of a F317L BCR-ABL mutation may be associated with resistance to dasatinib in Philadelphia chromosome-positive leukemia.F317L BCR-ABL突变的存在或出现可能与费城染色体阳性白血病对达沙替尼的耐药性有关。
J Clin Oncol. 2006 Nov 20;24(33):e51-2. doi: 10.1200/JCO.2006.08.9128.
4
Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.达沙替尼：一种用于治疗慢性粒细胞白血病和费城染色体阳性急性淋巴细胞白血病的酪氨酸激酶抑制剂。
Clin Ther. 2007 Nov;29(11):2289-308. doi: 10.1016/j.clinthera.2007.11.005.
5
Isolated central nervous system relapse in patient with blast-crisis chronic myeloid leukemia in durable complete cytogenetic remission on dasatinib treatment: pharmacokinetics and ABL mutation analysis in cerebrospinal fluid.达沙替尼治疗处于持久完全细胞遗传学缓解期的急变期慢性髓性白血病患者出现孤立性中枢神经系统复发：脑脊液中的药代动力学及ABL突变分析
Leuk Lymphoma. 2013 Jul;54(7):1557-9. doi: 10.3109/10428194.2012.745933. Epub 2012 Dec 22.
6
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib.对达沙替尼有反应的e19a2 BCR/ABL1慢性髓性白血病中的T315I突变。
Leuk Res. 2010 Sep;34(9):e240-2. doi: 10.1016/j.leukres.2010.03.036. Epub 2010 May 5.
7
Dasatinib for the treatment of Philadelphia chromosome-positive chronic myelogenous leukaemia after imatinib failure.达沙替尼用于治疗伊马替尼治疗失败后的费城染色体阳性慢性髓性白血病。
Expert Opin Pharmacother. 2007 Dec;8(18):3257-64. doi: 10.1517/14656566.8.18.3257.
8
Dasatinib-responsive chronic lymphocytic leukemia in a patient treated for coexisting chronic myeloid leukemia.在一名同时接受慢性髓性白血病治疗的患者中出现的对达沙替尼敏感的慢性淋巴细胞白血病。
Intern Med. 2013;52(22):2567-71. doi: 10.2169/internalmedicine.52.0392.
9
[Pharmacological properties and clinical efficacy of dasatinib hydrate (Sprycel), an anticancer drug for chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia].达沙替尼水合物（施达赛）用于慢性粒细胞白血病和费城染色体阳性急性淋巴细胞白血病的药理特性及临床疗效
Nihon Yakurigaku Zasshi. 2009 Sep;134(3):159-67. doi: 10.1254/fpj.134.159.
10
Dasatinib in chronic myelogenous leukemia.达沙替尼治疗慢性粒细胞白血病
N Engl J Med. 2006 Sep 7;355(10):1062-3; author reply 1063-4.

引用本文的文献

1
Pharmacokinetics of Four Tyrosine Kinase Inhibitors in Adult and Paediatric Chronic Myeloid Leukaemia Patients.四种酪氨酸激酶抑制剂在成人和儿童慢性髓性白血病患者中的药代动力学
Biomedicines. 2023 Sep 7;11(9):2478. doi: 10.3390/biomedicines11092478.
2
Diagnosis and management of adult central nervous system leukemia.成人中枢神经系统白血病的诊断与管理
Blood Sci. 2023 May 30;5(3):141-149. doi: 10.1097/BS9.0000000000000162. eCollection 2023 Jul.
3
Primary isolated central nervous system acute lymphoblastic leukemia with rearrangement: A case report.
伴有重排的原发性孤立性中枢神经系统急性淋巴细胞白血病：一例报告。
World J Clin Cases. 2022 May 6;10(13):4242-4248. doi: 10.12998/wjcc.v10.i13.4242.
4
Comparative pharmacokinetic analysis of the blood-brain barrier penetration of dasatinib and ponatinib in mice.达沙替尼和波纳替尼在小鼠体内血脑屏障穿透的比较药代动力学分析。
Leuk Lymphoma. 2021 Aug;62(8):1990-1994. doi: 10.1080/10428194.2021.1894647. Epub 2021 Mar 7.
5
Prolonged Survival of a Patient with Chronic Myeloid Leukemia in Accelerated Phase with Recurrent Isolated Central Nervous System Blast Crisis.一名处于加速期且反复出现孤立性中枢神经系统原始细胞危象的慢性髓性白血病患者的长期生存
Am J Case Rep. 2020 Sep 13;21:e922971. doi: 10.12659/AJCR.922971.
6
Overview of Current Targeted Anti-Cancer Drugs for Therapy in Onco-Hematology.血液肿瘤治疗中当前靶向抗癌药物概述
Medicina (Kaunas). 2019 Jul 28;55(8):414. doi: 10.3390/medicina55080414.
7
Isolated central nervous system blast crisis in a case of chronic myeloid leukemia on dasatinib.达沙替尼治疗慢性髓性白血病时出现的孤立性中枢神经系统急变期
South Asian J Cancer. 2018 Jul-Sep;7(3):170. doi: 10.4103/sajc.sajc_63_18.
8
Dasatinib as the salvage therapy for chronic myeloid leukemia with blast crisis and central nervous system involvement: A case report.达沙替尼作为慢性髓性白血病急变期合并中枢神经系统受累的挽救治疗：一例报告。
Oncol Lett. 2015 Apr;9(4):1957-1961. doi: 10.3892/ol.2015.2928. Epub 2015 Feb 3.